Full-Time

QA Computer System Admin II

Updated on 4/12/2025

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

Compensation Overview

$70k - $110k/yr

+ Short-term Incentives + Long-term Incentives

Mid, Senior

Monroe, GA, USA

Category
QA & Testing
System Administration
IT & Security
Quality Assurance
Required Skills
SQL
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Bachelor's Degree in Computer Sciences, Engineering or other related technical field with 2+ years of experience.
  • 3 years of relevant experience in a GMP regulated environment required.
  • SQL and database knowledge.
  • At least 2 years’ experience in laboratory software administration, including SQL*LIMS, LabWare, MODA, Empower and others QC instruments.
  • Technical problem-solving skills in the area of regulated 21 CFR laboratory instrumentation and data integrity.
  • Experience with Microsoft Word, Excel, Power Point Access.
  • Must Demonstrate effectiveness in ability to train others.
  • Availability to the network via remote connection after normal business hours and required.
  • Knowledge of Industry guidelines (ISPE, PDA), US and international regulations (FDA, ICH, ISO, EU) for GMP regulated environments.
Responsibilities
  • Administer all datagroups, users and permissions within the LIMS, Empower and other QC system.
  • Support troubleshooting of cross instance configuration from other sites in the network and inbound and outbound LIMS communication with EBM systems.
  • Review and update software operational and administrative SOP's.
  • Provide and conduct training on LIMS.
  • Involve in activities related to new instruments that will be installed and will be communicated with LIMS and Empower.
  • Support on validation's and related documentation for new functionality and upgrades to any computer systems including LIMS at the site.
  • Maintain data integrity, including performing assessments, periodic reviews and disaster recovery per FDA guidelines and company SOP's.
  • Assist analysts in troubleshooting issues via remote connection after business hours.
  • Monitoring/Control of the SQL LIMS Database, and other QC instruments.
  • Provide technical subject matter expert (SME) support for authoring and reviewing Data Integrity Assessments, Risk Assessments, and Remediation Plans.
  • Provide regulatory and internal compliance guidance for computer systems commissioning, qualification and validation activities.
  • Review and approve computer system related validation documents and quality system records such as deviations, CAPA, and change control.
  • Participate on teams to determine the root cause and corrective actions for problems associated with investigations.
  • Perform, support and review periodic reviews of qualification and computer system validations ensuring compliance with the qualified/validated state of the systems.
  • Establish and enhance the relationships between IT, Automation, Validation, manufacturing units through collaboration, respectful challenge, and ability to support QA decisions.
  • Participate in audits and regulatory agency inspections as a representative of QA Systems.
Desired Qualifications
  • Relevant experience in GMP regulated environment preferred.
  • Technical understanding and experience computerized and automation platform, such as LIMs, DeltaV, Honeywell, Rockwell PLC, Siemens XFP.
  • Knowledge in ISA88, Batch Control.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, with plans for up to 15 product launches by FY2024. Takeda's products are aimed at healthcare providers, hospitals, and patients around the world, and the company collaborates with about 41,000 suppliers to support its operations. Unlike many competitors, Takeda emphasizes patient-centric values, ensuring that the needs of patients guide its work. Additionally, Takeda is committed to environmental sustainability, recognizing the connection between environmental health and human health. The company's goal is to innovate and provide life-changing treatments while also promoting a healthier planet.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.